Intrahepatic bile duct hamartoma with cholangitis as the first manifestation combined with type 2 diabetes: a case report

Abstract

CLC Number:

R587.1

LIU Chongxiao, HUANG Song, BEI Pengjian, XU Yanhong, LI Xiaohua, ZHANG Hongli. Intrahepatic bile duct hamartoma with cholangitis as the first manifestation combined with type 2 diabetes: a case report[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(06): 436-438.

Figures/Tables2

项目	空腹	0.5 h	2 h
血糖（mmol/L）	14.24	15.45	22.76
胰岛素（pmol/L）	53.31	61.68	52.73
C肽（nmol/L）	2.01	1.98	2.07

References15

[1]	Guo Y, Jain D, Weinreb J. von Meyenburg complex: current concepts and imaging misconceptions[J].J Comput Assist Tomogr,2019,43(6): 846-851. doi:10.1097/RCT.0000000000000904pmid:31356525
[2]	Lin S, Weng Z, Xu J, et al. A study of multiple biliary hamartomas based on 1697 liver biopsies[J].Eur J Gastroenterol Hepatol,2013,25(8): 948-952. doi:10.1097/MEG.0b013e32835fb9ee URL
[3]	Redston MS, Wanless IR. The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies[J].Mod Pathol,1996,9(3): 233-237.
[4]	Pech L, Favelier S, Falcoz MT, et al. Imaging of von Meyenburg complexes[J].Diagn Interv Imaging,2016,97(4): 401-409. doi:10.1016/j.diii.2015.05.012 URL
[5]	Sinakos E, Papalavrentios L, Chourmouzi D, et al. The clinical presentation of von Meyenburg complexes[J].Hippokratia,2011,15(2): 170-173. pmid:22110302
[6]	Boraschi P, Scalise P, Tarantini G, et al. MR imaging features of multiple biliary hamartomas (von Meyenburg complex): a pictorial review and differential diagnosis[J].J Med Imaging Radiat Oncol,2021,65(3): 323-330. doi:10.1111/ara.v65.3 URL
[7]	Tröltzsch M, Borte G, Kahn T, et al. Non-invasive diagnosis of von Meyenburg complexes[J].J Hepatol,2003,39(1): 129. pmid:12821055
[8]	Courcet JB, Minello A, Prieur F, et al. Compound heterozygousPKHD1variants cause a wide spectrum of ductal plate malformations[J].Am J Med Genet A,2015,167A(12): 3046-3053.
[9]	Yoshida S, Kurokohchi K, Ueno T, et al. Hepatic von Meyenburg complex: a trigger of severe portal hypertension[J].Liver Int,2009,29(4): 614-615. doi:10.1111/j.1478-3231.2008.01903.xpmid:19018981
[10]	van Vlerken LG, van Leeuwen MS, Schipper ME, et al. The“von Meyenburg complex”: an unusual cause of cholangitis?[J].Clin Res Hepatol Gastroenterol,2011,35(11): 762-764. doi:10.1016/j.clinre.2011.07.004 URL
[11]	Shah RN, Forster EM. von Meyenburg complexes found incidentally in a patient with acute cholangitis[J].Clin Gastroenterol Hepatol,2019,17(12): e140. doi:10.1016/j.cgh.2018.05.030 URL
[12]	Hashimoto M, Ouchi M, Norose J, et al. Bile duct hamartomas (von Meyenburg complexes) associated with a bacterial infection: case report of elderly diabetic patient[J].Geriatr Gerontol Int,2011,11(4): 534-536. doi:10.1111/j.1447-0594.2011.00700.xpmid:21951779
[13]	Morinaga T, Imai K, Yamashita YI, et al. Multicystic biliary hamartoma with extremely elevated CA19-9[J].Scand J Gastroenterol,2017,52(8): 916-919. doi:10.1080/00365521.2017.1322140 URL
[14]	Song JS, Lee YJ, Kim KW, et al. Cholangiocarcinoma arising in von Meyenburg complexes[J].Pathol Int,2008,58(8): 503-512. doi:10.1111/pin.2008.58.issue-8 URL
[15]	Röcken C, Pross M, Brucks U, et al. Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes)[J].Arch Pathol Lab Med,2000,124(11): 1704-1706. doi:10.5858/2000-124-1704-COIALWpmid:11079031

Intrahepatic bile duct hamartoma with cholangitis as the first manifestation combined with type 2 diabetes: a case report

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables2

References15

Related Articles15

Recommended Articles

Metrics

Comments

[1]	ZHENG Xiaoyan, YI Huahua, ZHOU Min.Issues requiring attention in clinical diagnosis and treatment of diabetes mellitus combined with pulmonary infection[J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(1): 13-18.
[2]	HUANG Yuanhao, SHEN Yuanyuan, HAN Tao, ZHANG Bingqing, FENG Wenhuan.Glucose in the target range of time is associated with chronic complications of diabetes[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(05): 359-362.
[3]	WANG Weiming.Interpretation of Chinese expert consensus on understanding and management of renal anemia in diabetic kidney disease[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 137-140.
[4]	BI Liming, WANG Zhaohui.Research progress on pathogenesis of diabetic nephropathy[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 201-205.
[5]	GAO Yulian, FENG Yun, NI Lei.Research progress of drug-resistant gram-negative bacteria bloodstream infection in diabetic population[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 124-127.
[6]	ZHANG Mengxiao, SUN Shuoshuo, WEI Xiao, ZHANG Shaohong, CHEN Guofang, LIU Chao.Ketogenic diet promotes hepatic lipid accumulation in db/db mice[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 56-63.
[7]	MIAO Ya, LIU Lili, HOU Tianzhichao, YAN Qinghua, PANG Yi, WU Chunxiao, CHENG Minna, SHI Yan, LI Yanyun, TIAN Jingyan.Risk analysis of malignant tumor incidence in pre-diabetes patients in Shanghai[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(06): 435-440.
[8]	RUAN Ming, HOU Tianzhichao, WANG Haiyan, et al.Geometric deep learning and computational medicine research prospects of “preventing disease” in pre diabete[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(06): 475-481.
[9]	LU Lin, DAI Yang, WANG Xiaoqun, et al.Several advances of translational research in cardiovascular diseases[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 369-372.
[10]	.[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 349-352.
[11]	XU Qing, SHAO Huiying, CHEN Shuai, QUAN Jinwei, ZHOU Qingfen, WANG Minhui.The tele-nursing education and guidance ameliorate coronary plaque progression in patients with type 2 diabetes mellitus[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 330-333.
[12]	.[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 344-348.
[13]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 373-375.
[14]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 376-380.
[15]	SUN Yan, DAI Danjiao, CHEN Zhiwei, ZHANG Huaqing.Effect of canagliflozin on urinary albumin / creatinine ratio and urinary podocyte-associated protein nephrin in patients with early diabetic kidney disease[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(06): 387-391.